Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,973 | 1,862 | 2,893 | 2,741 | 1,696 |
| Cost of Goods | 791 | 872 | 1,325 | 1,212 | 781 |
| Gross Profit | 1,183 | 990 | 1,568 | 1,529 | 915 |
| Operating Expenses | 4,397 | 4,259 | 3,600 | 3,112 | 3,583 |
| Operating Income | -2,424 | -2,397 | -1,707 | -1,371 | -1,887 |
| Other Income | 418 | 15 | 269 | -248 | 386 |
| Pre-tax Income | -2,006 | -2,382 | -1,438 | -1,619 | -1,501 |
| Net Income Continuous | -2,006 | -2,382 | -1,438 | -1,619 | -1,501 |
| Net Income | $-2,006 | $-2,382 | $-1,438 | $-1,619 | $-1,501 |
| EPS Basic Total Ops | -0.23 | -0.28 | -0.18 | -0.27 | -0.19 |
| EPS Basic Continuous Ops | -0.23 | -0.28 | -0.17 | -0.26 | -0.19 |
| EPS Diluted Total Ops | -0.28 | -0.28 | -0.18 | -0.27 | -0.19 |
| EPS Diluted Continuous Ops | -0.23 | -0.28 | -0.17 | -0.26 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.25 | -0.18 | -0.24 | -0.18 |
| EBITDA(a) | $-2,377 | $-2,337 | $-1,642 | $-1,307 | $-1,820 |